25.04.2017 Opalesque Exclusive: WBB enters buy-side with new healthcare long/short strategy
Benedicte Gravrand, Opalesque Geneva:

WBB Securities, a US financial services firm and boutique investment bank since 2001, has a long history within the biotech industry. Managing partner Steve Brozak has been associated with biotech for the last 25-30 years, and was involved with some of the most notable IPOs in the industry, such as Celgene. So launching a healthcare strategy out of their ne

Print